Merck
All Photos(2)

S3378

Sigma-Aldrich

Spironolactone

97.0-103.0%

Synonym(s):
4-Pregnen-21-oic acid-17α-ol-3-one-7α-thiol γ-lactone 7-acetate, 7α-(Acetylthio)-17α-hydroxy-3-oxopregn-4-ene-21-carboxylic acid γ-lactone
Empirical Formula (Hill Notation):
C24H32O4S
CAS Number:
Molecular Weight:
416.57
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NA.77

Quality Level

Assay

97.0-103.0%

mp

207-208 °C (lit.)

solubility

chloroform: complete 50 mg/ml, clear, faintly yellow

originator

Pfizer

SMILES string

CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13

InChI

1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1

InChI key

LXMSZDCAJNLERA-ZHYRCANASA-N

Gene Information

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

1 of 4

This Item
PHR2886BP306S1200000
Spironolactone 97.0-103.0%

Sigma-Aldrich

S3378

Spironolactone

Spironolactone pharmaceutical secondary standard, certified reference material

Supelco

PHR2886

Spironolactone

Spironolactone British Pharmacopoeia (BP) Reference Standard

BP306

Spironolactone

Spironolactone European Pharmacopoeia (EP) Reference Standard

S1200000

Spironolactone

assay

97.0-103.0%

assay

-

assay

-

assay

-

solubility

chloroform: complete 50 mg/ml, clear, faintly yellow

solubility

-

solubility

-

solubility

-

originator

Pfizer

originator

-

originator

-

originator

-

Quality Level

200

Quality Level

-

Quality Level

-

Quality Level

-

mp

207-208 °C (lit.)

mp

207-208 °C (lit.)

mp

207-208 °C (lit.)

mp

207-208 °C (lit.)

Gene Information

human ... HSD17B1(3292), NR3C2(4306)
rat ... Ar(24208)

Gene Information

-

Gene Information

human ... NR3C2(4306)

Gene Information

human ... NR3C2(4306)

Application

Spironolactone was added to rat diet to study the effect of long-term spironolactone use on renal function.

Biochem/physiol Actions

Spironolactone reduces aldosterone-induced potassium/magnesium loss and myocardial fibrosis. It reduces hypertension, improves the endothelial function and reduces the overall morbidity and mortality in patients with chronic heart failure. Spironolactone improves nitric oxide bioactivity and vascular endothelial vasodilator dysfunction.
Spironolactone is a competitive aldosterone receptor antagonist. Used as potassium sparing diuretic.

Features and Benefits

This compound is featured on the Nuclear Receptors (Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Preparation Note

Spironolactone yields clear, faint yellow solution in chloroform at 50 mg/ml.

Pictograms

Health hazard

Signal Word

Danger

Hazard Statements

Hazard Classifications

Carc. 2 - Repr. 1B - STOT RE 2

Storage Class Code

6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service